Charles River Laboratories | 债务利息支出



金融业
股票价格
USD
资产
USD 7.14B
现金及等价物
USD 213.77M
销售成本
USD 722.27M
流动资产
USD 1.45B
流动负债
USD 1.12B
债务
USD 2.63B
EBIT
USD 75.82M
EBITDA
USD 258.06M
员工
18.6K
EPS每股收益
USD 2.39
股本和储备
USD 3.16B
销售毛利
USD 271.96M
债务利息支出
USD 23.78M
利息收入
USD 1.1
贷款资金
USD 2.14B
市值
USD 8.36B
净收入
USD -276.56M
营业费用
USD 918.41M
营业利润
USD 75.82M
普通股股本
USD 49.22M
PE价格收益
USD 43.58
税前利润
USD 170.03M
销售收入
USD 994.2M
销售和管理费用
USD 196.14M
股票
USD 299.1M
贸易债权人
USD 148.8M
应收帐款人
USD 1.43B


债务利息支出 更改 日
Agilent USD 27M 1000K 2025-09
Align Technology USD 2M 660K 2023-03
Bio-Rad Laboratories USD 12.3M 100K 2025-09
Bruker USD 20M 4.3M 2025-09
Cardinal Health USD 88M 8M 2025-12
Charles River Laboratories USD 23.78M 1.63M 2025-12
Cigna USD 157.92B 157.58B 2025-09
Concord Medical Services Hldg CNY 84.37M 32.34M 2023-06
CVS Health USD 787M 3M 2025-12
Danaher USD 55M 12M 2025-12
Dentsply International USD 23M 1000K 2025-09
Elevance Health USD 366M 15M 2025-12
Galapagos EUR 1.72M 940K 2025-09
Hologic USD 27.6M 1000K 2025-12
Humana USD 146M 22M 2025-12
Illumina USD 25M 0 2025-09
Incyte USD 582K 10K 2025-12
Intrexon USD 2K 5K 2024-06
IQVIA Holdings USD 193M 4M 2025-12
Laboratory Of America USD 55M 1000K 2025-12
Lonza CHF 84M 14M 2025-06
McKesson USD 63M 11M 2025-12
Merck EUR 126M 47M 2025-09
Mettler Toledo International USD 17.39M 307K 2025-12
Novartis USD 281M 8M 2025-09
Pfizer USD 711M 59M 2025-12
Quest Diagnostics USD 69M 2M 2025-09
Revvity USD 23.51M 742K 2025-12
Thermo Fisher Scientific USD 365M 18M 2025-12
United Therapeutics USD 3M 4.3M 2025-09
UnitedHealth USD 974M 29M 2025-12
Veradigm USD 1.25M 641K 2022-09
Waters USD 8.62M 18.02M 2025-12
West Pharmaceutical Services USD 200K 100K 2025-09


Charles River Laboratories 债务利息支出 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.